Materialise’s patient-specific, craniomaxillofacial (CMF) implants will be offered through DePuy Synthes.
Materialise’s patient-specific, craniomaxillofacial (CMF) implants will be offered through DePuy Synthes.

3D printing software specialist Materialise has formed a new collaboration with DePuy Synthes, a supplier of medical devices, that will see Materialise’s patient-specific, craniomaxillofacial (CMF) implants being offered through DePuy Synthes TRUMATCH CMF Solutions company in Australia and Europe, excluding France.

‘At Materialise, we strive to make medical 3D printing accessible to every researcher, engineer, and clinician, through an open platform of software and services that help customize patient treatment,’ said Materialise founder and CEO, Wilfried Vancraen. ‘Together with DePuy Synthes, we have successfully enabled better surgical outcomes through surgical planning and patient-specific guides, and are proud that this new collaboration will now empower even more CMF surgeons to discover the benefits of 3D-printed, patient-specific implants as well.’

This story is reprinted from material from Materialise, with editorial changes made by Materials Today. The views expressed in this article do not necessarily represent those of Elsevier.